Drug intelligence / Profile preview

doxylamine succinate + ibuprofen

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Doxylamine succinate + ibuprofen is a combination of two small molecule drugs. Doxylamine succinate is an ethanolamine-derivative antihistamine with pronounced sedative and anticholinergic properties, commonly used as a short-term sleep aid and for relief of allergy or cold symptoms. It acts primarily as a histamine H1 receptor antagonist, blocking the action of histamine in the body to reduce allergic symptoms and induce sedation. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, leading to decreased synthesis of prostaglandins involved in pain, inflammation, and fever. The combination may be used off-label for symptomatic relief where both analgesia/anti-inflammatory effects (from ibuprofen) and sedative/antihistaminic effects (from doxylamine) are desired[5][6][7]. There are no known significant interactions between these two drugs when taken together[1][3].

02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)mAChR (Muscarinic acetylcholine receptors)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on doxylamine succinate + ibuprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on doxylamine succinate + ibuprofen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call